Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-08

Clinical Trial Update: Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk Hypertensives

View source ↗

Summary

An observational, non-interventional study evaluating telmisartan in high-risk hypertension patients has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telmisartan (Telmisartan)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension, Obesity | Status: COMPLETED